Skip to main content
. 2015 Apr 21;26(7):1421–1427. doi: 10.1093/annonc/mdv186

Table 1.

Description of HER2 mutations and clinical outcomes of patients treated with dacomitinib

HER2 mutation type
Partial responses noted
HER2 amplification status by FISH (HER2/CEP17 ratio) Mutation
Amino acid change (and nucleotide change)
Alternate nomenclature
(based on HGVS guidelines)
Survival from start of dacomitinib (months)
Exon 20 insertion (12-bp duplication) Not tested p. A775_G776insYVMA (c. 2324_2325ins12) p.Y772_A775dup (c.2313_2324dup) 23
Exon 20 insertion (12-bp duplication) <2.0 p. A775_G776insYVMA (c. 2324_2325ins12) p.Y772_A775dup (c.2313_2324dup) 10
Exon 20 insertion (12-bp duplication) <2.0 p. A775_G776insYVMA (c. 2324_2325ins12) p.Y772_A775dup (c.2313_2324dup) 16
Exon 20 insertion (12-bp duplication) Not tested p. A775_G776insYVMA (c. 2324_2325ins12) p.Y772_A775dup (c.2313_2324dup)  3
Exon 20 insertion (12-bp duplication) Not tested p. A775_G776insYVMA (c. 2324_2325ins12) p.Y772_A775dup (c.2313_2324dup)  2
Exon 20 insertion (12-bp duplication) Not tested p. A775_G776insYVMA (c. 2324_2325ins12) p.Y772_A775dup (c.2313_2324dup)  9
Exon 20 insertion (12-bp duplication) Not tested p. A775_G776insYVMA (c. 2324_2325ins12) p.Y772_A775dup (c.2313_2324dup)  9
Exon 20 insertion (12-bp duplication) Not tested p. A775_G776insYVMA (c. 2324_2325ins12) p.Y772_A775dup (c.2313_2324dup) 29
Exon 20 insertion (12-bp duplication) <2.0 p. A775_G776insYVMA (c. 2324_2325ins12) p.Y772_A775dup (c.2313_2324dup)  5
Exon 20 insertion (12-bp duplication) Not tested p. A775_G776insYVMA (c. 2324_2325ins12) p.Y772_A775dup (c.2313_2324dup)  2+
Exon 20 insertion (12-bp duplication) Not tested p. A775_G776insYVMA (c. 2324_2325ins12) p.Y772_A775dup (c.2313_2324dup)  7
Exon 20 insertion (12-bp duplication) Not tested p. A775_G776insYVMA (c. 2324_2325ins12) p.Y772_A775dup (c.2313_2324dup) 14
Exon 20 insertion (12-bp duplication) <2.0 p. A775_G776insYVMA (c. 2324_2325ins12) p.Y772_A775dup (c.2313_2324dup) 26+
Exon 20 insertion (9-bp duplication)
Partial response
Duration 14 months
<2.0 p. P780_Y781insGSP (c. 2339_2340ins GGCTCCCCA) p.G778_P780dup
(c.2331_2339dup)
27
Exon 20 insertion (9-bp duplication)
Partial response
Duration 11 months
<2.0 p. P780_Y781insGSP
(c. 2339_2340ins GGCTCCCCA)
p.G778_P780dup
(c.2331_2339dup)
25+
Exon 20 insertion (9 bp) Not tested Not specified Nor specified  4
Exon 20 insertion (9 bp) <2.0 Not specified Not specified  8
Exon 20 insertion (3 bp) <2.0 Not specified Not specified  3
Exon 20 insertion (3 bp) Not tested p. G776 > VC (c.2326_2327insTGT) p.G776delinsVC
(c.2326_2327insTGT)
21
Exon 20 insertion (3 bp) Not tested p. G776 > VC (c.2326_2327insTGT) p.G776delinsVC
(c.2326_2327insTGT)
 2
Exon 20 insertion Not tested Not specified Not specified  7
Exon 20 insertion <2.0 Not specified Not specified 18+
Exon 20 insertion Not tested Not specified Not specified 21+
Exon 20 indel
Partial response
Duration 3+ months
Not tested p. M774delinsWLV
(c.2320A > TGGCTGG)
p. M774delinsWLV
(c.2320delins
TGGCTGG)
23+
Exon 20 indel <2.0 p. G776 > LC
(c. 2326G > TTGT)
p.G776delinsLC
(c.2326delinsTTGT)
 9
Exon 20 missense mutation Not tested p. V777L (c.2329G > T) p. V777L (c.2329G > T)  3

HGVS, Human Genome Variation Society.